MOR - MorphoSys AG Sof marja

MorphoSys Corp - MOR emitenti grafik logotipi

MorphoSys AG (MOR) sog'liqni saqlash gigantlari bilan hamkorlikda maqsadli antitanalarni ishlab chiqish orqali risklarni minimallashtiradi. O'rtacha savdo marjalari FDA ning qat'iy nazorati va onkologik dori vositalari uchun eksklyuziv patentlar tufayli yuzaga kelgan burilishni ko'rsatmoqda. Innovatsiyalarga bo'lgan barqaror talab aktivni defensiv qiladi va uni makroiqtisodiy tebranishlardan ajratadi. -226.90 qiymati kompaniyaning joriy operatsion samaradorligini belgilovchi bazaviy qiymat sifatida belgilangan.

morphosys.com (MOR) Kompaniya sotuv marjasi: 04.07.2022 - 10.08.2024 davri uchun

MorphoSys AG (MOR) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahliliyoti:morphosys.com - MOR
MorphoSys Corporation ishlab chiqargan mahsulot

Ushbu ko'rsatkich sof foydaning daromadga nisbatini hisoblab, xarajatlarni boshqarish samaradorligini aniqlaydi. U barcha operatsion va soliq to'lovlaridan keyin qolgan daromad qismini ko'rsatadi. MorphoSys AG (MOR) uchun ushbu metrika royalti to'lovlari va antitanalar portfelining diversifikatsiyasi tufayli barqarorlashgan. Sof foyda marjasini tahlil qilish abnormal cho'qqilarni aniqlash imkonini beradi, bu esa investorlarga aktiv uchun haddan tashqari ko'p to'lov qilishdan qochishga yordam beradi.

Raqobatchilar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Kitov Pharma - Sof foyda bo'yicha sotuv rentabelligi|American Oncology Network (AONC) - Sof marja|BeiGene - Sotuvning sof marjinal rentabelligi|Checkpoint Therapeutics, Inc. (CKPT) - Sof foyda bo'yicha sotuv rentabelligi|ELEV (Elevation Oncology, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|iCAD Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi IKNA|Sotuvning sof marjinal rentabelligi notablelabs.com|Sof foyda bo'yicha sotuv rentabelligi VIRX (Viracta Therapeutics Inc.)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)